OTC · Medical - Pharmaceuticals

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Stock

$0.65 +0.00% OTC: BJTRF Healthcare

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is an entity primarily engaged in the manufacturing, retailing, and wholesale distribution of traditional Chinese medicine and various healthcare products, catering to both bulk purchasers and individual consumers. The company further provides traditional Chinese medical consultation and treatment services.

Valuation

MetricValue
Price$0.65
Market Cap$542.78M
P/E Ratio14.49
P/B Ratio1.37
P/S Ratio3.80
EPS (TTM)$0.04
52-Week High$0.65
52-Week Low$0.65
Dividend Yield7.69%

Financials & Margins

MetricValue
ROE9.67%
ROA8.52%
ROCE10.60%
Gross Margin61.16%
Operating Margin31.20%
Net Margin26.25%
Debt/Equity0.03
Current Ratio19.65

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.6B$1.7B$1.5B$12.5B$1.5B
Operating Profit$770.0M$811.0M$624.0M$574.0M$473.0M
Net Profit$608.0M$645.0M$4.2B$500.0M$397.0M
EPS$0.73$0.77$0.65$4.66$0.47
Op Margin49.5%46.9%40.9%4.6%31.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.9B$4.2B$4.4B$4.6B$4.7B
Total Liabilities$319.0M$506.0M$414.0M$313.0M$292.0M
Cash$1.7B$2.0B$1.0B$1.8B$2.2B
Borrowings$128.0M$103.0M$132.0M$123.0M$127.0M

Latest News

Beijing Tong Ren Tang Sparks New Momentum in the Inheritance of TCM through Student Ambassador Programme TMX Newsfile · Jul 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$778.0M$557.0M$461.0M$-217.0M$868.0M
Investing Cash Flow$-294.0M$659.0M$-2.4B$1.3B$-79.0M
Financing Cash Flow$-74.0M$-87.0M$-90.0M$-79.0M$-88.0M
Net Cash Flow$226.0M$327.0M$-991.0M$773.0M$452.0M
Free Cash Flow$754.0M$518.0M$290.0M$-260.0M$827.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.67
EV / EBITDA7.37
FCF Yield16.77%
Quick Ratio13.16
Interest Coverage207.03
Return 1Y161.03%
Return 3Y402.65%
Return 5Y—

Ownership

Insiders Held71.68%
Institutions Held3.04%
Institutions Float Held10.75%
Institutional HolderSharesReport Date
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund6,043,2822026-04-30
iShares, Inc.-iShares Core MSCI Emerging Markets ETF4,309,0002026-06-30
Dodge & Cox Funds-Dodge & Cox Emerging Markets Stock Fund2,182,7002026-03-31
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund2,196,6162026-03-31
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT.1,785,0002026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGYTFAllergy Therapeutics plc $0.15 +0.00% -5.05 $756.30M 0.00%
AVNBFAvon Technologies Plc $22.49 +0.00% 41.69 $662.29M 0.71%
BOIRFBoiron S.A. $31.50 +0.00% 14.78 $546.91M 4.98%
CLVSFCellaVision AB (publ) $14.00 +0.00% 27.39 $333.92M 2.14%
FDMDF4DMedical Limited $2.53 +0.00% -12.25 $1.52B 0.00%

About Beijing Tong Ren Tang Chinese Medicine Company Limited

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is an entity primarily engaged in the manufacturing, retailing, and wholesale distribution of traditional Chinese medicine and various healthcare products, catering to both bulk purchasers and individual consumers. The company further provides traditional Chinese medical consultation and treatment services. Its operational scope is divided across three key regions: Hong Kong, Mainland China, and other international markets. With a substantial retail presence, it manages 23 outlets in Hong Kong and an additional 46 stores distributed across Asia, Oceania, North America, and Europe. All its merchandise is marketed under the well-known Tong Ren Tang brand. This historic firm, established in 1669, maintains its corporate headquarters in Wan Chai, Hong Kong.

Beijing Tong Ren Tang Chinese Medicine Company Limited is headquartered in HK.

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) stock trades at $0.65 with a market capitalization of $542.78M. The stock is valued at a price-to-earnings (P/E) ratio of 14.49, price-to-book of 1.37, price-to-sales of 3.80. Over the past 52 weeks the stock has ranged between $0.65 and $0.65, and currently trades at its 52-week high. It pays a dividend yielding 7.69%.

On profitability, Beijing Tong Ren Tang Chinese Medicine Company Limited generates a return on equity (ROE) of 9.67%, return on capital employed of 10.60%, an operating margin of 31.20%, a net profit margin of 26.25%.

Official website: cm.tongrentang.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides